Get the Stockscreener App
0.3414
5.17%
-0.0186
IGC Pharma Inc stock is traded at $0.3414, with a volume of 506.68K.
It is down -5.17% in the last 24 hours and up +12.49% over the past month.
India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.
See More
Previous Close:
$0.36
Open:
$0.3408
24h Volume:
506.68K
Relative Volume:
0.23
Market Cap:
$28.64M
Revenue:
$1.22M
Net Income/Loss:
$-14.15M
P/E Ratio:
-1.3131
EPS:
-0.26
Net Cash Flow:
$-6.55M
1W Performance:
-6.77%
1M Performance:
+12.49%
6M Performance:
+6.75%
1Y Performance:
-25.77%
1-Day Range:
$0.336
$0.3485
1-Week Range:
$0.336
$0.3919
52-Week Range:
$0.2525
$0.48
IGC Pharma Inc Stock (IGC) Company Profile
Name
IGC Pharma Inc
Sector
Industry
Phone
301-983-0998
Address
4336 Montgomery Avenue, Bethesda, MD
Compare IGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.3414 | 30.20M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
IGC Pharma Inc Stock (IGC) Latest News
What institutional investors are buying IGC Pharma Inc. stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com
What are IGC Pharma Inc. company’s key revenue driversTop Growth Insights For Consistent Profits - jammulinksnews.com
How to build a dashboard for IGC Pharma Inc. stockDay Trading Setup Forecast with Trend Model - Newser
Is IGC Pharma Inc. a growth stock or a value stockValue Investing Guidance To Watch Now - jammulinksnews.com
Can IGC Pharma Inc. stock recover from recent declineReal-Time Investment Signal Forecast with AI - Newser
RSI Crosses Above 30 for IGC Pharma Inc. — Reversal in SightCommunity Strategy With High Win Rate Backtested - beatles.ru
Price Channel Expanding on IGC Pharma Inc.’s ChartAlpha Driven Watchlist With Alerts Published - metal.it
How IGC Pharma Inc. stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
What's driving IGC's earnings surprises recently? - AInvest
Should you wait for a breakout in IGC Pharma Inc.Low Risk Stock Selection Strategy Guide - Newser
Can IGC maintain its Q2 2025 earnings momentum? - AInvest
What are the technical indicators suggesting about IGC Pharma Inc.Expert Picks Data Feed For Consistent Profits - jammulinksnews.com
Why is IGC Pharma Inc. stock attracting strong analyst attentionAI Powered Entry Points From AI Tools - jammulinksnews.com
Should I hold or sell IGC Pharma Inc. stock in 2025Beginner Investor Signals For Every Investor - jammulinksnews.com
Published on: 2025-07-28 19:27:20 - beatles.ru
What are analysts’ price targets for IGC Pharma Inc. in the next 12 monthsInvest confidently with data-backed picks - jammulinksnews.com
Technical Bounce Expected in IGC Pharma Inc. Next WeekReal Time Stock Movement Analysis Indicates Breakout - metal.it
IGC Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Entry Zone Strategy for Consistent Profit - Newser
How does IGC Pharma Inc. generate profit in a changing economyCapitalize on fast-growing investment opportunities - jammulinksnews.com
How to use a screener to detect IGC Pharma Inc. breakoutsSwing Reversal Forecast Based on Patterns - Newser
Top Risks to Consider Before Buying IGC Pharma Inc. StockStable Entry High Return Opportunities in Focus - metal.it
When is IGC Pharma Inc. stock expected to show significant growthStrong return on assets - jammulinksnews.com
How strong is IGC Pharma Inc. company’s balance sheetUnlock steady growth with low-risk stocks - jammulinksnews.com
What markets is IROH expanding into Is IGC Pharma Inc. stock a good long term investment optionExplosive capital appreciation - jammulinksnews.com
What is IGC Pharma Inc. company’s growth strategyRecord-breaking capital gains - jammulinksnews.com
What is the risk reward ratio of investing in IGC Pharma Inc. stockConsistent high-yield stocks - jammulinksnews.com
What is the dividend policy of IGC Pharma Inc. stockGet daily updates on promising stocks - jammulinksnews.com
How Resilient Is IGC Pharma Inc. Stock During Economic DownturnsCapital Growth Picks - Newser
What drives IGC Pharma Inc. stock priceRobust financial gains - PrintWeekIndia
What analysts say about IGC Pharma Inc. stockExtraordinary earning power - PrintWeekIndia
Does IGC Pharma Inc. stock pay reliable dividendsHigh-octane gains - jammulinksnews.com
IGC Pharma Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
IGC Pharma to Present Advanced AI Platforms for Alzheimer's Disease at the AAIC 2025 - ACCESS Newswire
IGC Pharma's New AI Platform Could Help 400M People Get Earlier Alzheimer's Diagnosis - Stock Titan
Is IGC Pharma Inc. a good long term investmentOverwhelming financial success - jammulinksnews.com
What makes IGC Pharma Inc. stock price move sharplyFree Top Growth Stock Recommendations - Newser
IGC Pharma Inc Stock (IGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):